1207 TRIPLE THERAPY WITH DACLATASVIR (DCV; BMS-790052),...

Journal of Hepatology 2012 / 4 Vol. 56

1207 TRIPLE THERAPY WITH DACLATASVIR (DCV; BMS-790052), PEGINTERFERON ALFA-2A AND RIBAVIRIN IN HCV-INFECTED PRIOR NULL AND PARTIAL RESPONDERS: 12-WEEK RESULTS OF PHASE 2B COMMAND-2 TRIAL

Ratziu, V., Gadano, A., Pol, S., Hézode, C., Ramji, A., Cheng, W., Sulkowsk, M., Everson, G., Diva, U., McPhee, F., Wind-Rotolo, M., Hughes, E.A., Yin, P.D., Schnittman, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
56
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(12)61219-7
Date:
April, 2012
File:
PDF, 71 KB
english, 2012
Conversion to is in progress
Conversion to is failed